S-1

Company

Maze Therapeutics, Inc.

Filed

October 17, 2025

Accession Number

0001193125-25-242526

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →